ANALYSIS OF FACTORS INFLUENCING HEMATOLOGIC RECOVERY IN PATIENTS TREATED WITH HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW REINFUSION

被引：0
|
作者：
WILLIAMS, SF
BITRAN, JD
BARKER, CM
GRADISHAR, WJ
KAMINER, LS
GOLOMB, HM
ROYSTON, K
机构：
[1] UNIV CHICAGO,JOINT SECT HEMATOL ONCOL,CHICAGO,IL 60637
[2] MICHAEL REESE MED CTR,CHICAGO,IL 60637
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1987年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：231 / 231
页数：1
相关论文
共 50 条
  • [1] ANALYSIS OF FACTORS INFLUENCING HEMATOLOGIC RECOVERY IN PATIENTS TREATED WITH HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW REINFUSION
    KAMINER, L
    WILLIAMS, S
    BITRANI, J
    GOLOMB, H
    WESTBROOK, C
    ROYSTON, K
    CLINICAL RESEARCH, 1986, 34 (04): : A967 - A967
  • [2] ANALYSIS OF FACTORS INFLUENCING HEMATOLOGIC RECOVERY IN PATIENTS TREATED WITH HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW
    WILLIAMS, SF
    BITRAN, JD
    BARKER, CM
    GRADISHAR, WJ
    KAMINER, LS
    GOLOMB, HM
    ROYSTON, K
    BONE MARROW TRANSPLANTATION, 1987, 2 : 146 - 146
  • [3] PLASMA PHARMACOKINETICS OF HIGH-DOSE ORAL MELPHALAN IN PATIENTS TREATED WITH TRIALKYLATOR CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW REINFUSION
    CHOI, KE
    RATAIN, MJ
    WILLIAMS, SF
    GOLICK, JA
    BESCHORNER, JC
    FULLEM, LJ
    BITRAN, JD
    CANCER RESEARCH, 1989, 49 (05) : 1318 - 1321
  • [4] ERYTHROPOIETIC ACTIVITY IN PATIENTS TREATED WITH HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    LITTLEWOOD, TJ
    BENTLEY, DP
    CAVILL, I
    BRITISH JOURNAL OF HAEMATOLOGY, 1985, 61 (03) : 563 - 563
  • [5] AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND HIGH-DOSE CHEMOTHERAPY
    PHILIP, T
    PLOUVIER, E
    ROZENBAUM, A
    BIRON, P
    VUVAN, H
    EHRSAM, A
    BERGERAT, JP
    BEHART, C
    CORDIER, JF
    FREYCON, F
    HERVE, P
    LYON MEDICAL, 1981, 246 (15): : 137 - 148
  • [6] HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    SPITZER, G
    DICKE, K
    ZANDER, AR
    JAGANNATH, S
    VELLEKOOP, L
    FREIREICH, EJ
    CANCER, 1984, 54 (06) : 1216 - 1225
  • [7] HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW TRANSFUSION
    SPITZER, G
    DICKE, KA
    VERMA, DS
    ZANDER, A
    LITAM, J
    DISTEFANO, A
    LANZOTTI, V
    EXPERIMENTAL HEMATOLOGY, 1979, 7 : 38 - 53
  • [8] FACTORS INFLUENCING SURVIVAL IN RELAPSED OR REFRACTORY HODGKINS-DISEASE TREATED BY HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANT
    AHMED, T
    COOK, P
    BEER, M
    RAZIS, E
    FELDMAN, E
    LAKE, D
    MITTELMAN, A
    ALI, M
    PRETI, R
    BLOOD, 1993, 82 (10) : A147 - A147
  • [9] HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR MYELOMA
    MCELWAIN, TJ
    SELBY, PJ
    GORE, ME
    VINER, C
    MELDRUM, M
    MILLAR, BC
    MALPAS, JS
    EUROPEAN JOURNAL OF HAEMATOLOGY, SUPPL NO 51, VOL 43, 1989: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON MULTIPLE MYELOMA - BIOLOGY, PATHOPHYSIOLOGY, PROGNOSIS AND TREATMENT, 1989, : 152 - 156
  • [10] AUTOLOGOUS BONE-MARROW TRANSPLANT HASTENS HEMATOPOIETIC RECOVERY POST HIGH-DOSE CHEMOTHERAPY
    DUNPHY, F
    AUBER, M
    SPITZER, G
    DICKE, K
    JAGANNATH, S
    HORWITZ, L
    SPINOLO, J
    BUZDAR, A
    HOLMS, F
    JABBOURY, K
    HORTOBAGYI, G
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 181 - 181
12345